Oxycodone Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

It is formulated by 42 pharmaceutical companies such as PURDUE PHARMA LP, GENUS LIFESCIENCES, DR REDDYS LABS SA and others. It is marketed under 11 brand names, including OXYCONTIN, OXYCODONE HYDROCHLORIDE, OXYCODONE AND ASPIRIN and others. Available in 32 different strengths, such as 80MG, 10MG, 15MG and others, and administered through 5 routes including TABLET, EXTENDED RELEASE;ORAL, SOLUTION;ORAL, CAPSULE;ORAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 42 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"97691","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXAYDO","family_id":"6243898b7b514dce89dd","publication_number":"US7201920B2","cleaned_patent_number":"7201920","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-16","publication_date":"2007-04-10","legal_status":"Granted"} US7201920B2 Formulation 10 Apr, 2007 Granted 16 Mar, 2025
{"application_id":"45025","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US8557291B2","cleaned_patent_number":"8557291","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-21","publication_date":"2013-10-15","legal_status":"Granted"} US8557291B2 Formulation 15 Oct, 2013 Granted 21 Mar, 2025
{"application_id":"45022","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US7399488B2","cleaned_patent_number":"7399488","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-24","publication_date":"2008-07-15","legal_status":"Granted"} US7399488B2 Formulation 15 Jul, 2008 Granted 24 Mar, 2025
{"application_id":"45023","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US7771707B2","cleaned_patent_number":"7771707","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-24","publication_date":"2010-08-10","legal_status":"Granted"} US7771707B2 Formulation 10 Aug, 2010 Granted 24 Mar, 2025
{"application_id":"45024","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US8449909B2","cleaned_patent_number":"8449909","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-24","publication_date":"2013-05-28","legal_status":"Granted"} US8449909B2 Formulation 28 May, 2013 Granted 24 Mar, 2025
{"application_id":"3995","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e6444ccd37ea442bbd60","publication_number":"US10696684B2","cleaned_patent_number":"10696684","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-30","publication_date":"2020-06-30","legal_status":"Granted"} US10696684B2 Molecular 30 Jun, 2020 Granted 30 Mar, 2025
{"application_id":"4147","ingredient":"NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e6444ccd37ea442bbd60","publication_number":"US9073933B2","cleaned_patent_number":"9073933","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-30","publication_date":"2015-07-07","legal_status":"Granted"} US9073933B2 Molecular 07 Jul, 2015 Granted 30 Mar, 2025
{"application_id":"4004","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e6444ccd37ea442bbd60","publication_number":"US10407434B2","cleaned_patent_number":"10407434","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-30","publication_date":"2019-09-10","legal_status":"Expired"} US10407434B2 Molecular 10 Sep, 2019 Expired 30 Mar, 2025
{"application_id":"117386","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e6444ccd37ea442bbd60","publication_number":"US12060361B2","cleaned_patent_number":"12060361","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-30","publication_date":"2024-08-13","legal_status":"Expired"} US12060361B2 Formulation 13 Aug, 2024 Expired 30 Mar, 2025
{"application_id":"4017","ingredient":"NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e6444ccd37ea442bbd60","publication_number":"US9522919B2","cleaned_patent_number":"9522919","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-30","publication_date":"2016-12-20","legal_status":"Expired"} US9522919B2 Molecular Formulation 20 Dec, 2016 Expired 30 Mar, 2025
{"application_id":"45026","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US8758813B2","cleaned_patent_number":"8758813","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-10","publication_date":"2014-06-24","legal_status":"Granted"} US8758813B2 24 Jun, 2014 Granted 10 Jun, 2025
{"application_id":"44215","ingredient":"NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","trade_name":"TROXYCA ER","family_id":"554e0edd0efb43dbbc25","publication_number":"US8685443B2","cleaned_patent_number":"8685443","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-07-03","publication_date":"2014-04-01","legal_status":"Expired"} US8685443B2 01 Apr, 2014 Expired 03 Jul, 2025
{"application_id":"88029","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"1a69898d0d7c4f29bc88","publication_number":"US7976870B2","cleaned_patent_number":"7976870","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-01","publication_date":"2011-07-12","legal_status":"Expired"} US7976870B2 12 Jul, 2011 Expired 01 Jun, 2027
{"application_id":"85501","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US8808741B2","cleaned_patent_number":"8808741","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2014-08-19","legal_status":"Patented case"} US8808741B2 19 Aug, 2014 Patented case 24 Aug, 2027
{"application_id":"85533","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US11304908B2","cleaned_patent_number":"11304908","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2022-04-19","legal_status":"Patented case"} US11304908B2 Formulation 19 Apr, 2022 Patented case 24 Aug, 2027
{"application_id":"85293","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US11304909B2","cleaned_patent_number":"11304909","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2022-04-19","legal_status":"Granted"} US11304909B2 19 Apr, 2022 Granted 24 Aug, 2027
{"application_id":"123312","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US11964056B1","cleaned_patent_number":"11964056","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2024-04-23","legal_status":"Patented case"} US11964056B2 Formulation 23 Apr, 2024 Patented case 24 Aug, 2027
{"application_id":"140358","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US12246094B2","cleaned_patent_number":"12246094","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2025-03-11","legal_status":"Granted"} US12246094B2 Formulation 11 Mar, 2025 Granted 24 Aug, 2027
{"application_id":"140360","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US12280152B2","cleaned_patent_number":"12280152","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2025-04-22","legal_status":"Granted"} US12280152B2 Formulation 22 Apr, 2025 Granted 24 Aug, 2027
{"application_id":"85507","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US8894988B2","cleaned_patent_number":"8894988","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2014-11-25","legal_status":"Patented case"} US8894988B2 Formulation 25 Nov, 2014 Patented case 24 Aug, 2027
{"application_id":"85515","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9492389B2","cleaned_patent_number":"9492389","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2016-11-15","legal_status":"Granted"} US9492389B2 Formulation 15 Nov, 2016 Granted 24 Aug, 2027
{"application_id":"85517","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9492391B2","cleaned_patent_number":"9492391","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2016-11-15","legal_status":"Granted"} US9492391B2 15 Nov, 2016 Granted 24 Aug, 2027
{"application_id":"85518","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9492392B2","cleaned_patent_number":"9492392","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2016-11-15","legal_status":"Granted"} US9492392B2 Formulation 15 Nov, 2016 Granted 24 Aug, 2027
{"application_id":"85519","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9492393B2","cleaned_patent_number":"9492393","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2016-11-15","legal_status":"Patented case"} US9492393B2 15 Nov, 2016 Patented case 24 Aug, 2027
{"application_id":"85522","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9763933B2","cleaned_patent_number":"9763933","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2017-09-19","legal_status":"Granted"} US9763933B2 Formulation 19 Sep, 2017 Granted 24 Aug, 2027
{"application_id":"85523","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9770416B2","cleaned_patent_number":"9770416","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2017-09-26","legal_status":"Granted"} US9770416B2 Formulation 26 Sep, 2017 Granted 24 Aug, 2027
{"application_id":"85525","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US9775808B2","cleaned_patent_number":"9775808","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-24","publication_date":"2017-10-03","legal_status":"Granted"} US9775808B2 Formulation 03 Oct, 2017 Granted 24 Aug, 2027
{"application_id":"44231","ingredient":"NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","trade_name":"TROXYCA ER","family_id":"554e0edd0efb43dbbc25","publication_number":"US7815934B2","cleaned_patent_number":"7815934","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-12-12","publication_date":"2010-10-19","legal_status":"Expired"} US7815934B2 Formulation 19 Oct, 2010 Expired 12 Dec, 2027
{"application_id":"86642","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"ROXYBOND","family_id":"b67e92d9516842c6a6c9","publication_number":"US10314788B2","cleaned_patent_number":"10314788","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-08-12","publication_date":"2019-06-11","legal_status":"Granted"} US10314788B2 Formulation 11 Jun, 2019 Granted 12 Aug, 2028
{"application_id":"86661","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"ROXYBOND","family_id":"b67e92d9516842c6a6c9","publication_number":"US7955619B2","cleaned_patent_number":"7955619","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-08-12","publication_date":"2011-06-07","legal_status":"Granted"} US7955619B2 Formulation 07 Jun, 2011 Granted 12 Aug, 2028
{"application_id":"87999","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"51307b7e553747e3ab7f","publication_number":"US8394408B2","cleaned_patent_number":"8394408","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-11","publication_date":"2013-03-12","legal_status":"Expired"} US8394408B2 Formulation 12 Mar, 2013 Expired 11 Mar, 2029
{"application_id":"87989","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"51307b7e553747e3ab7f","publication_number":"US8668929B2","cleaned_patent_number":"8668929","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-11","publication_date":"2014-03-11","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8668929B2 11 Mar, 2014 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 11 Mar, 2029
{"application_id":"87997","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"51307b7e553747e3ab7f","publication_number":"US8372432B2","cleaned_patent_number":"8372432","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-11","publication_date":"2013-02-12","legal_status":"Expired"} US8372432B2 Formulation 12 Feb, 2013 Expired 11 Mar, 2029
{"application_id":"87998","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"51307b7e553747e3ab7f","publication_number":"US8377453B2","cleaned_patent_number":"8377453","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-11-19","publication_date":"2013-02-19","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8377453B2 Formulation 19 Feb, 2013 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 19 Nov, 2029
{"application_id":"85506","ingredient":"OXYCODONE HYDROCHLORIDE","trade_name":"OXYCONTIN","family_id":"e5a5cd9fb6d44b3ebab7","publication_number":"US8894987B2","cleaned_patent_number":"8894987","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-29","publication_date":"2014-11-25","legal_status":"Patented case"} US8894987B2 Formulation 25 Nov, 2014 Patented case 29 Mar, 2030
{"application_id":"45035","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US10668060B2","cleaned_patent_number":"10668060","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-10","publication_date":"2020-06-02","legal_status":"Granted"} US10668060B2 Formulation 02 Jun, 2020 Granted 10 Dec, 2030
{"application_id":"45032","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US10004729B2","cleaned_patent_number":"10004729","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-10","publication_date":"2018-06-26","legal_status":"Granted"} US10004729B2 Formulation 26 Jun, 2018 Granted 10 Dec, 2030
{"application_id":"45030","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"8118b312729b48aa95c1","publication_number":"US9682075B2","cleaned_patent_number":"9682075","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-10","publication_date":"2017-06-20","legal_status":"Granted"} US9682075B2 Formulation 20 Jun, 2017 Granted 10 Dec, 2030
{"application_id":"88041","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"f6bffbddccbf4bfab9a6","publication_number":"US8597681B2","cleaned_patent_number":"8597681","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-21","publication_date":"2013-12-03","legal_status":"Expired"} US8597681B2 Formulation 03 Dec, 2013 Expired 21 Dec, 2030
{"application_id":"88052","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"f6bffbddccbf4bfab9a6","publication_number":"US8980319B2","cleaned_patent_number":"8980319","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-21","publication_date":"2015-03-17","legal_status":"Expired"} US8980319B2 Formulation 17 Mar, 2015 Expired 21 Dec, 2030
{"application_id":"88015","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"a65e2e5eb43642ba9e49","publication_number":"US9050335B1","cleaned_patent_number":"9050335","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-16","publication_date":"2015-06-09","legal_status":"Expired"} US9050335B2 Formulation 09 Jun, 2015 Expired 16 May, 2032
{"application_id":"88014","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"a65e2e5eb43642ba9e49","publication_number":"US8992975B2","cleaned_patent_number":"8992975","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-16","publication_date":"2015-03-31","legal_status":"Expired"} US8992975B2 Formulation 31 Mar, 2015 Expired 16 May, 2032
{"application_id":"88017","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"a65e2e5eb43642ba9e49","publication_number":"US9468636B2","cleaned_patent_number":"9468636","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-16","publication_date":"2016-10-18","legal_status":"Expired"} US9468636B2 18 Oct, 2016 Expired 16 May, 2032
{"application_id":"88010","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"a65e2e5eb43642ba9e49","publication_number":"US8741885B1","cleaned_patent_number":"8741885","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-16","publication_date":"2014-06-03","legal_status":"Expired"} US8741885B2 Formulation 03 Jun, 2014 Expired 16 May, 2032
{"application_id":"88011","ingredient":"ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","trade_name":"XARTEMIS XR","family_id":"a65e2e5eb43642ba9e49","publication_number":"US8658631B1","cleaned_patent_number":"8658631","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-16","publication_date":"2014-02-25","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US8658631B2 Formulation 25 Feb, 2014 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 16 May, 2032
{"application_id":"45061","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"e4e3336b86bc4d3385ee","publication_number":"US10646485B2","cleaned_patent_number":"10646485","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-09-02","publication_date":"2020-05-12","legal_status":"Granted"} US10646485B2 Formulation 12 May, 2020 Granted 02 Sep, 2036
{"application_id":"45058","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"e4e3336b86bc4d3385ee","publication_number":"US9737530B1","cleaned_patent_number":"9737530","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-09-02","publication_date":"2017-08-22","legal_status":"Granted"} US9737530B2 Formulation 22 Aug, 2017 Granted 02 Sep, 2036
{"application_id":"45060","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"e4e3336b86bc4d3385ee","publication_number":"US10188644B2","cleaned_patent_number":"10188644","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-09-02","publication_date":"2019-01-29","legal_status":"Granted"} US10188644B2 Formulation 29 Jan, 2019 Granted 02 Sep, 2036
{"application_id":"45059","ingredient":"OXYCODONE","trade_name":"XTAMPZA ER","family_id":"e4e3336b86bc4d3385ee","publication_number":"US9968598B2","cleaned_patent_number":"9968598","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-09-02","publication_date":"2018-05-15","legal_status":"Granted"} US9968598B2 Formulation 15 May, 2018 Granted 02 Sep, 2036

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Oxycodone

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.